FDA Investigator Hilary K Wagner
Hilary K Wagner has conducted inspections on 145 sites in 1 countries as of 20 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
145
Last Inspection Date:
20 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Hilary K Wagner:
Althea A Williams,
Amanda T Zick,
Andrew F Cohen,
Andrew M Abramowitz,
Ann B Okon,
Arthur G Hurst,
Benton M Ketron,
Brian J Ryan,
Bruce G Cooper,
Carla E Lavallee,
Carley R Anderson,
Carolyn J Cook,
Christopher S Fields,
Clinton V Giustra,
Crystal A Branch,
Dana A Razzano,
Daniel L Aisen,
David A Carlson,
David A Laplante,
David A Trent Carlson,
David M Mcnew,
David R Lattuca,
Diamond M Oden,
Dipesh K Shah,
Donald J Ullstrom,
Elizabeth H Davis,
Elizabeth H Slazak,
Erin L Nagel,
George C Amedro,
Gregory E Beichner,
Harry J Brewer,
Isaac N Baah,
James D Bridges,
Jeanette L Mcginnis,
Jerri E Lothrop,
Joanne M Schlossin,
Joel R Merriman,
Johnna L Bleem,
Joseph A Dinardo,
Joseph A Famiglietti,
Joseph J Vannelli,
Joseph Maselli,
Joseph Milcetic,
Joseph T Frost,
Joshua D Lopez,
Joy P Matthias,
Joyce A Williams,
Judy Keihl,
Julie Scoma,
Karen L Kosar,
Katelyn Astaub Zamperini,
Kathryn A Nagy,
Kazi Rafiquzzaman,
Kenneth G Klobus,
Kim M Downing,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kirk A Dymbrowski,
Kyle J Spencer,
Lauren E Blaser,
Linda M Sacco,
Marc S Neubauer,
Marlene L Davis,
Mary Alice B Garlipp,
Mary M Finn,
Marybeth Willis,
Matthew D Schnittker,
Michael A Charles,
Michael R Dominick,
Michael W Burd,
Morris Paul,
Nicholas C Mendiola,
Paul E Stein,
Peter M Trunk,
Randi Lynn Bodoh,
Richard K Glabach,
Robert J Veitch,
Russ E Davis,
Sarah A Meehan,
Sasha M Latonis,
Shannon A Dinardo,
Sonia E Ortiz,
Steven J Libal,
Tammy S Notto,
Thomas L Bellonte,
Valerie A Potopsingh,
Wendy M Stone,
William P Chilton
Hilary K Wagner's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2017 | FDA 483 | Wells Enterprises, Inc. - Form 483, 2017-07-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more